Delivery Order SPE2DB22D1017-SPE2DB25FYPKL
Award Date 8/28/25
Potential Completion Date 8/29/25
Potential Value $5.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $2,881.19 delivery order to AmerisourceBergen Drug Corp for Crexont ER 87.5 mg-350 mg capsules (120 count) on August 21, 2025, with ultimate completion by August 22, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract utilizing competitively-awarded pricing. The product will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,342.98 to AmerisourceBergen Drug Corp for the supply of Crexont ER 70 mg-280 mg capsules (120 count) on July 21, 2025, with ultimate completion scheduled for July 22, 2025. This non-set-aside, firm fixed-price delivery order will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Crexont ER 52.5 mg–210 mg capsules (120-count) valued at $3,309.28. This firm fixed-price delivery order, with an ultimate completion date of August 20, 2025, represents a competitively awarded non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. The award was performed at AmerisourceBergen's Conshohocken, Pennsylvania location,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for CREXONT ER 70 mg–280 mg capsules (120-count packaging) with a ceiling value of $3,237.83. This firm fixed-price delivery order is non-competitive, representing one of numerous pharmaceutical supply transactions executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the company's...
- The Defense Logistics Agency awarded a $2,614.19 delivery order to AmerisourceBergen Drug Corp for CREXONT ER 52.5 mg-210 mg capsules (120-count) on August 20, 2025, with completion scheduled for August 21, 2025. This firm fixed price, non-set-aside contract represents a direct procurement of pharmaceutical products to support federal medical supply needs. The award was performed from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $1,064.88, is for the supply of 120 capsules of the medication CREXONT ER 87.5 MG-350 MG. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,783.96 firm fixed-price delivery order contract, which lacks a set-aside designation, is for the provision of 4566822808 ! CREXONT ER 52.5 MG-210 MG CAP 120S medical products. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $9,025.18 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy) in 100-count bottles. This firm fixed price delivery order, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $4,470.48 to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed price, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Creon DR 24,000 unit capsules (100 count) with a ceiling value of $2,262.52 and an ultimate completion date of August 11, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...